Abstract
Boron neutron capture therapy (BNCT) is a cancer-selective radiotherapy to treat malignant tumors using a nuclear reaction of boron isotopes in tumor-localizing drug molecules. To evaluate the efficacy of boron drugs for BNCT, it is crucial to measure the distribution of boron drugs in cells. Here, we present the direct imaging of cellular uptake of boron cluster compound by stimulated Raman scattering microscopy. We demonstrate quantitative analysis of spatial distributions of disodium mercaptoundecahydrododecaborate (BSH)-cholesterol in HeLa cells.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
